-
Mashup Score: 0US FDA pushes decision on Moderna's RSV vaccine to end of this month - 13 hour(s) ago
The U.S. drug regulator has pushed back its decision on Moderna’s respiratory syncytial virus (RSV) vaccine due to “administrative constraints” and will complete the review by the end of this month, the company said on Friday.
Source: www.reuters.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0
Dr. Lal PathLabs , India’s biggest diagnostics firm by revenue, posted a bigger profit for the fourth straight quarter on Thursday, led by the addition of more labs and increased demand for medical tests.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says - 15 hour(s) ago
Cipla is open to partnering with U.S. drugmaker Eli Lilly to market its blockbuster obesity treatment drugs in India, the company’s CEO said on Friday.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1US FDA pushes decision on Moderna's RSV vaccine to end of this month - 17 hour(s) ago
The U.S. drug regulator has pushed back its decision on Moderna’s respiratory syncytial virus (RSV) vaccine due to “administrative constraints” and will complete the review by the end of this month, the company said on Friday.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Novavax erases doubts about its ability to remain in business - 17 hour(s) ago
COVID-19 vaccine maker Novavax , on Friday, erased doubts about its ability to remain in business by removing a so-called “going concern” notice.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Novavax shares soar on license deal with Sanofi at lofty valuation - 18 hour(s) ago
Novavax on Friday struck a licensing deal of up to $1.2 billion with Sanofi for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm at double its current market capitalization.
Source: www.reuters.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2US to post influenza A wastewater data online to help with bird flu probe, official says - 18 hour(s) ago
The U.S. Centers for Disease Control and Prevention (CDC) is planning to post data on influenza A found in wastewater in a public dashboard possibly as soon as Friday that could offer new clues into the outbreak of H5N1 bird flu in cattle herds.
Source: www.reuters.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0
Dr. Lal PathLabs , India’s biggest diagnostics firm by revenue, posted a bigger profit for the fourth straight quarter on Thursday, led by the addition of more labs and increased demand for medical tests.
Source: www.reuters.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0
Talks to draw up a global pact to help fight future pandemics have ended without a draft agreement, sources close to the process said on Friday.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says - 19 hour(s) ago
Cipla is open to partnering with U.S. drugmaker Eli Lilly to market its blockbuster obesity treatment drugs in India, the company’s CEO said on Friday.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
The U.S. drug regulator has pushed back its decision on Moderna's respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and will complete the review by the end of this month, the company said on Friday. https://t.co/nHiR6ogRDj https://t.co/nHiR6ogRDj